LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade
Kyung Jin Yoo(Lemuel Shattuck Hospital), George Fromm(United Therapeutics (United States))
Cited by 19
Related Papers
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
|Cancer Cell|2024|177
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
|Journal for ImmunoTherapy of Cancer|2018|49